Sugi Predict

Sugi Predict / Compounds / SCHEMBL6494483

SCHEMBL6494483

SCHEMBL6494483

N#C[C@@H]1C=CCN1C(=O)[C@@H](N)CCC(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 11/20 0.47
▸ DPP8 Q6V1X1 10/20 0.47
▸ DPP7 Q9UHL4 9/20 0.47
▸ DPP9 Q86TI2 4/20 0.47
▸ FAP Q12884 2/20 0.42
▸ SLC15A1 P46059 1/20 0.39
▸ PREP P48147 2/20 0.39
▸ CTSL P07711 1/20 0.39
▸ CTSB P07858 1/20 0.39
▸ CTSK P43235 1/20 0.39
▸ PSEN1 P49768 1/20 0.38
▸ PSEN2 P49810 1/20 0.38
▸ APH1B Q8WW43 1/20 0.38
▸ NCSTN Q92542 1/20 0.38
▸ APH1A Q96BI3 1/20 0.38
▸ PSENEN Q9NZ42 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7183513 1.00 DPP4 (0.47) DPP4DPP8DPP7DPP9FAP
SCHEMBL6167493 1.00 DPP4 (0.47) DPP4DPP8DPP7DPP9FAP
SCHEMBL7177541 0.90 DPP4 (0.44) DPP4DPP8DPP7DPP9FAP
SCHEMBL6171475 0.83 DPP4 (0.44) DPP4DPP8DPP7DPP9FAP
SCHEMBL6171477 0.83 DPP4 (0.44) DPP4DPP8DPP7DPP9FAP
SCHEMBL7425586 0.82 DPP4 (0.52) DPP4DPP8DPP7DPP9FAP
SCHEMBL6167577 0.82 DPP4 (0.52) DPP4DPP8DPP7DPP9FAP
SCHEMBL6491309 0.82 DPP4 (0.52) DPP4DPP8DPP7DPP9FAP
SCHEMBL7191378 0.81 DPP4 (0.60) DPP4DPP8DPP7DPP9FAP
SCHEMBL7185307 0.81 DPP4 (0.60) DPP4DPP8DPP7DPP9FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070719-A1 Inhibitors of dipeptidyl peptidase iv GUILFORD PHARMACEUTICALS 2005-03-31 — — US disclosed
US-6645995-B2 Dipeptidyl peptidase-IV (DPP-IV); treating type II diabetes in a human; amino acid amides of 2-cyanopyrrolidine NOVO NORDISK A/S (DK) 2003-11-11 — — US disclosed
US-20020103384-A1 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV KANSTRUP ANDERS (DK) 2002-08-01 — — US disclosed
US-6380398-B2 COMPOUNDS SUCH AS (S,S)1-(2-AMINO-3,3-DIMETHYL-BUTYRYL)-2,5-DIHYDRO-1H-PYRROLE-2 -CARBONITRILE ADMINISTERED AS ANTIDIABETIC AGENTS; DIPEPTIDYL PEPTIDASE-IV (DPP-IV) NOVO NORDISK A/S (DK) 2002-04-30 — — US disclosed
US-20010031780-A1 New therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV NOVO NORDISK A/S (DK) 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031780-A1 New therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV DPP4, DPP7, DPP9 DPP4 1/4885DPP8 5/4885DPP7 2/4885
US-20020103384-A1 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV DPP4, DPP7, DPP9 DPP4 1/4885DPP8 5/4885DPP7 2/4885
US-20050070719-A1 Inhibitors of dipeptidyl peptidase iv DPP4, DPP3, DPP7 DPP4 1/4885DPP8 5/4885DPP7 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.